Cargando…
A novel monoclonal antibody associated with glucoside kills gastric adenocarcinoma AGS cells based on glycosylation target
Glycosylation results in the production of glycans which are required for certain proteins to function. These glycans are also present on cell surfaces where they help maintain cell membrane integrity and are a key component of immune recognition. As such, cancer has been shown to alter glycosylatio...
Autores principales: | Xu, Heng, Dun, Boying, Liu, Beiyi, Mysona, David, She, Jin‐Xiong, Ma, Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465190/ https://www.ncbi.nlm.nih.gov/pubmed/35946053 http://dx.doi.org/10.1111/jcmm.17504 |
Ejemplares similares
-
Inflammatory Serum Proteins Are Severely Altered in Metastatic Gastric Adenocarcinoma Patients from the Chinese Population
por: Wang, Jiangnan, et al.
Publicado: (2015) -
Development and Evaluation of Monoclonal Antibodies for the Glucoside of T-2 Toxin (T2-Glc)
por: Maragos, Chris M., et al.
Publicado: (2013) -
Mycophenolic Acid Inhibits Migration and Invasion of Gastric Cancer Cells via Multiple Molecular Pathways
por: Dun, Boying, et al.
Publicado: (2013) -
Engineering Heterologous Production of Salicylate Glucoside and Glycosylated Variants
por: Qi, Ruiquan, et al.
Publicado: (2018) -
Monoclonal antibody‐mediated killing of tumour cells by neutrophils
por: Heemskerk, Niels, et al.
Publicado: (2018)